Abstract
The intensity of putative benzodiazepine withdrawal symptoms was evaluated as part of a double blind placebo-controlled study of benzodiazepines and behaviour therapy in the management of agoraphobia. During the first phase of that study, some subjects were switched from low dose diazepam to placebo, and others remained on diazepam. Symptoms were evaluated in long-term benzodiazepine users (n=30) and non-users (n=32) when they first entered the study and 4 weeks later, after both groups had been randomized to either diazepam or placebo, using eight analog rating scales measuring commonly reported withdrawal symptoms. At baseline, both users and non-users reported a substantial number of symptoms, with higher levels in the more anxious patients, but no differences between groups. After the transition to either diazepam or placebo, the users switched to placebo reported significantly higher levels of symptoms than users switched to diazepam and non-users combined. Multiple regression analysis suggested that the increase in symptoms was associated with the increase in anxiety, which was higher in the withdrawing group than the other three groups. These results raise questions concerning the extent to which withdrawal symptoms uniquely characterize benzodiazepine withdrawal. They confirm the common assumption that an increase in symptoms often accompanies withdrawal from benzodiazepines, but suggest that such symptoms are not so intense as to make withdrawal excessively difficult, at least in low-dose users.
Similar content being viewed by others
References
American Psychiatric Association (1990) Benzodiazepine dependence, toxicity, and abuse. APA, Washington, DC
Arana GW, Hyman SE (1991) Handbook of psychiatric drug therapy. Little, Brown and Co., Boston
Ashton H, Golding JF (1989) Tranquillisers: prevalence, predictors and possible consequences. Data from a large United Kingdom survey. Br J Addict 84:541–546
Beasley CM, Sayler ME, Weiss AM, Potvin JH (1992) Fluoxetine: activating and sedating effects at multiple fixed doses. J Clin Psychopharmacol 12:328–333
Bowden CL, Fisher JG (1980) Safety and efficacy of long-term diazepam therapy. South Med J 73:1581–1584
Busto U, Sellers EM, Naranjo CA, Cappell HD, Sanchez-Craig M Simkins J (1986a) Patterns of benzodiazepine abuse and dependence. Br J Addict 81:87–94
Busto U, Sellers EM, Naranjo CA, Cappell HD, Sanchez-Craig M, Sykora K (1986b) Withdrawal reaction after long-term therapeutic use of benzodiazepines. N Engl J Med 315:854–859
Clinthorne JK, Cisin, IH, Balter MB, Mellinger GD, Uhlenhuth EH (1986) Changes in popular attitudes and beliefs about tranquillizers. Arch Gen Psychiatry 43:527–532
Dunbar GC, Perera, MH, Jenner FA (1989) Patterns of benzodiazepine use in Great Britain as measured by a general population survey. Br J Psychiatry 155:836–841
Gray JA (1987) Interactions between drugs and behaviour therapy. In: Eysenck H, Martin I (eds) Theoretical foundations of behaviour therapy. Plenum Press, New York, pp 433–447
Gudex C (1991) Adverse effects of benzodiazepines. Soc Sci Med 33:587–596
Hanin B, Marks J (1988) Dependance aux benzodiazepines et syndrome de sevrage: revue de la literature. Psychiatr Psychobiol 3:347–364
Hayward P, Wardle J, Higgitt A (1989) Benzodiazepine research: current findings and practical consequences. Br J Clin Psychol 28:307–327
Higgitt AC, Lader MH Fonagy P (1985) Clinical management of benzodiazepine dependence. Br Med J 291:688–690
Higgitt A, Golombok S, Fonagy P, Lader M (1987) Group treatment of benzodiazepine dependence. Br J Addict 82:517–532
Hollister LE, Motzenbecker FP, Degan RO (1961) Withdrawal reactions from chlordiazepoxide (“Librium”). Psychopharmacologia 2:63–68
Kraupl Taylor F (1989) The damnation of benzodiazepines. Br J Psychiatry 154:697–704
Lapierre YD, Tremblay A, Gagnon A, Monpremier P, Berliss H, Oyewumi LK (1982) A therapeutic and discontinuation study of clobazam and diazepam in anxiety neurosis. J Clin Psychiatry 43:372–374
Laughren TP, Battey Y, Greenblatt DJ Harrop DS (1982) A controlled trial of diazepam withdrawal in chronically anxious outpatients. Acta Psychiatr Scand 65:171–179
Margraf J, Ehlers A, Roth WT, Clark DB, Sheikh J, Agras WS, Taylor CB (1991) How “blind” are double-blind studies? J Consult Clin Psychol 59:184–187
Noyes R, Garvey MJ, Cook BL, Perry PJ (1988) Benzodiazepine withdrawal: a review of the evidence. J Clin Psychiatry 49:382–389
Perera KMH. Jenner FA (1987) Some characteristics distinguishing high and low dose users of benzodiazepines. Br J Addict 82:1329–1333
Petursson H, Lader MH (1981) Withdrawal from long-term benzodiazepine treatment. Br Med J 283:643–645
Rodrigo EK, Williams P (1986) Frequency of self-reported “anxiolytic withdrawal” symptoms in a group of female students experiencing anxiety. Psychol Med 16:467–472
Roy-Byrne PP (1991) Benzodiazepines: dependence and withdrawal. In: Roy-Byrne PP, Cowley DS (eds) Benzodiazepines in clinical practice: benefits and risks. American Psychiatric Press, Washington DC, pp 131–153
Sanchez-Craig M, Kay G, Busto U, Cappell H (1986) Cognitive-behavioural treatment for benzodiazepine dependence. Lancet 1:388
Simpson RJ, Power KG, Wallace LA, Butcher MH, Swanson V, Simpson EC (1990) Controlled comparison of the characteristics of long-term benzodiazepine users in general practice. Br J Gen Pract 40:22–26
Smith DE, Landry MJ (1990) Benzodiazepine dependency discontinuation: focus on the chemical dependency detoxification setting and benzodiazepine-polydrug abuse. J Psychiatr Res 24 [Suppl 2]: 145–156
Spielberger CD, Gorsuch RL, Lushene RE, Vagg, PR, Jacobs JA (1983) Manual for the state-trait anxiety inventory. Consulting Psychologist Press, Palo Alto, Calif.
Swinson RP, Pecknold JC Kirby ME (1987) Benzodiazepine dependence. J Affect Disord 13:109–118
Tyrer P, Rutherford D, Huggett T (1981) Benzodiazepine withdrawal symptoms and propranolol. Lancet 1:520–522
Wardle J, Hayward P, Higgitt A, Stabl M, Blizard B, Gray J (1994) Effects of concurrent diazepam treatment on the outcome of exposure therapy in agoraphobia. Behav Res Ther 32:203–215
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hayward, P., Wardle, J., Higgitt, A. et al. Changes in “withdrawal symptoms” following discontinuation of low-dose diazepam. Psychopharmacology 125, 392–397 (1996). https://doi.org/10.1007/BF02246023
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02246023